Reflect Scientific, Inc. (RSCF)
| Previous Close | 0.0488 |
| Open | 0.0460 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0437 - 0.0500 |
| 52 Week Range | 0.0400 - 0.1400 |
| Volume | |
| Avg. Volume | 47,844 |
| Market Cap | 4.283M |
| Beta (5Y Monthly) | 1.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | May 10, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireReflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company
OREM, Utah, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in the development of ultra-low temperature storage solutions, today provided an update on the previously announced landmark order from a premier BioPharma company, valued at over $500,000. This notable agreement, the most significant single order in the Company's history, involves supplying our cutting-edge storage freezers to a BioPharma entity with a market capitalization of $40 billion. Due to a s
- GlobeNewswire
Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology
OREM, Utah, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in temperature control solutions, is excited to announce the successful testing of its groundbreaking liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency's increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators
- GlobeNewswire
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company
OREM, Utah, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a pioneering manufacturer in ultra-low temperature storage solutions, is thrilled to announce its most significant single order ever, valued at over $500,000. This landmark deal involves the provision of our state-of-the-art storage freezers to a premier BioPharma company with a market valuation of $40 billion. The contract involves the supply of state-of-the-art storage freezers designed to secure and effici
